| scholarly article | Q13442814 |
| P50 | author | Frederick Wolfe | Q59689263 |
| Chester V. Oddis | Q114404222 | ||
| P2093 | author name string | Clifton O Bingham | |
| Larry W Moreland | |||
| Michael H Weisman | |||
| Nancy E Lane | |||
| H Ralph Schumacher | |||
| James R O'Dell | |||
| Daniel O Clegg | |||
| Allen D Sawitzke | |||
| Thomas J Schnitzer | |||
| Domenic J Reda | |||
| Daniel E Furst | |||
| Helen Shi | |||
| Roland W Moskowitz | |||
| Jerry A Molitor | |||
| David E Yocum | |||
| H James Williams | |||
| Kenneth D Brandt | |||
| John J Cush | |||
| John D Bradley | |||
| Crystal L Harris | |||
| Marguerite A Klein | |||
| Christopher G Jackson | |||
| Michele M Hooper | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoarthritis | Q62736 |
| knee osteoarthritis | Q1777118 | ||
| glucosamine | Q32907954 | ||
| P1104 | number of pages | 14 | |
| P304 | page(s) | 795-808 | |
| P577 | publication date | 2006-02-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis | |
| P478 | volume | 354 |
| Q84600122 | Q84600122 |
| Q33678954 | 10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin |
| Q51710557 | A 10-day course of SPA therapy is beneficial for people with severe knee osteoarthritis. A 24-week randomised, controlled pilot study. |
| Q35249579 | A 40-month multicentre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA project |
| Q92155858 | A Double-Blind, Randomized Controlled 12-Week Follow-Up Trial to Evaluate the Efficacy and Safety of Polycan in Combination with Glucosamine for the Treatment of Knee Osteoarthritis |
| Q34242933 | A Randomized Controlled Exploratory Evaluation of Standardized Ayurvedic Formulations in Symptomatic Osteoarthritis Knees: A Government of India NMITLI Project |
| Q36112637 | A Review on the Management of Hip and Knee Osteoarthritis |
| Q52606114 | A Traditional Herbal Formula Xianlinggubao for Pain Control and Function Improvement in Patients with Knee and Hand Osteoarthritis: A Multicenter, Randomized, Open-Label, Controlled Trial. |
| Q27334344 | A clinical trial comparing Lanconone® with ibuprofen for rapid relief in acute joint pain. |
| Q33767965 | A combination of Scutellaria baicalensis and Acacia catechu extracts for short-term symptomatic relief of joint discomfort associated with osteoarthritis of the knee |
| Q34248533 | A commercialized dietary supplement alleviates joint pain in community adults: a double-blind, placebo-controlled community trial |
| Q34588403 | A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals |
| Q35675778 | A flood of health functional foods: what is to be recommended? |
| Q36075955 | A hierarchy of patient-reported outcomes for meta-analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals |
| Q36492429 | A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. |
| Q33873693 | A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes |
| Q42292745 | A pharmacoproteomic study confirms the synergistic effect of chondroitin sulfate and glucosamine. |
| Q37772730 | A potential role for avocado- and soybean-based nutritional supplements in the management of osteoarthritis: a review |
| Q35638355 | A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. |
| Q29394573 | A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort |
| Q43815643 | A randomized, double-blind, placebo-controlled clinical trial to investigate the effect of Cynatine® FLX on symptoms of osteoarthritis |
| Q64097564 | A small molecule promotes cartilage extracellular matrix generation and inhibits osteoarthritis development |
| Q37092804 | Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. |
| Q24240288 | Acupuncture for peripheral joint osteoarthritis |
| Q35979658 | Acute liver injury associated with glucosamine dietary supplement |
| Q46602405 | Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial |
| Q55234571 | Ajuga decumbens stimulates mesenchymal stem cell differentiation and regenerates cartilage in a rabbit osteoarthritis model. |
| Q46276610 | Akkermansia muciniphila May Determine Chondroitin Sulfate Ameliorating or Aggravating Osteoarthritis |
| Q33582481 | Alternative medicine research in clinical practice: a US national survey |
| Q31105383 | An Easy Access to Organic Salt-Based Stimuli-Responsive and Multifunctional Supramolecular Hydrogels. |
| Q52691461 | An Observational 1-Month Trial on the Efficacy and Safety of Promerim for Improving Knee Joint. |
| Q36967279 | Anastrozole for malignant and benign conditions: present applications and future therapeutic integrations |
| Q34156091 | Angelica Sinensis polysaccharides stimulated UDP-sugar synthase genes through promoting gene expression of IGF-1 and IGF1R in chondrocytes: promoting anti-osteoarthritic activity |
| Q82976466 | Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination |
| Q36850809 | Arthritis and pain. Current approaches in the treatment of arthritic pain |
| Q35247174 | Arthroscopic surgery for knee osteoarthritis? Just say no |
| Q36606633 | Association between use of specialty dietary supplements and C-reactive protein concentrations. |
| Q64935552 | Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. |
| Q30402387 | Ayurveda-modern medicine interface: A critical appraisal of studies of Ayurvedic medicines to treat osteoarthritis and rheumatoid arthritis |
| Q47789675 | Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial |
| Q37131543 | Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the "Magenta osteoarthritis study". |
| Q38616606 | Biomimetic collagenous scaffold to tune inflammation by targeting macrophages |
| Q36500122 | Bone alterations are associated with ankle osteoarthritis joint pain |
| Q40073591 | Bone marrow lesions predict progression of cartilage defects and loss of cartilage volume in healthy middle-aged adults without knee pain over 2 yrs. |
| Q35092924 | Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine |
| Q51051347 | Cartilage repair strategies in the knee: A survey of Turkish surgeons. |
| Q34557021 | Celecoxib for osteoarthritis. |
| Q34238267 | Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis |
| Q34584630 | Celecoxib: a review of its use in the management of arthritis and acute pain |
| Q42339984 | Changes in serum levels of glucosamine and sulphate after ingestion of glucosamine sulphate with and without simultaneous ingestion of glucose |
| Q46480778 | Characterization of mice with targeted deletion of the gene encoding core 2 beta1,6-N-acetylglucosaminyltransferase-2. |
| Q36245717 | Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate |
| Q34655436 | Chondroitin and glucosamine in the management of osteoarthritis: an update |
| Q22000858 | Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study |
| Q24186473 | Chondroitin for osteoarthritis |
| Q36713898 | Chondroitin sulfate as a structure-modifying agent |
| Q37391095 | Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study |
| Q34002078 | Chondroitin sulfate in the management of hip and knee osteoarthritis: an overview |
| Q36059429 | Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations. |
| Q46914099 | Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes |
| Q34906145 | Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI |
| Q92949806 | Chondroprotective Factors in Osteoarthritis: a Joint Affair |
| Q93054033 | Chondroprotective effect of Nigella sativa oil in the early stages of osteoarthritis: an experimental study in rabbits |
| Q35981248 | Chondroprotective effects of a proanthocyanidin rich Amazonian genonutrient reflects direct inhibition of matrix metalloproteinases and upregulation of IGF-1 production by human chondrocytes |
| Q36050737 | Clinical Assessment of Low-dose Osteoinductive Protein as a Stand-alone Regimen in Self-reported Osteoarthritis |
| Q57802270 | Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee |
| Q24602794 | Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT |
| Q39320631 | Clinical significance of the placebo effect |
| Q62399335 | Clinical update: treating osteoarthritis |
| Q28212371 | Collagen Synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of Glucosamine HCl and chondroitin sulfate |
| Q39539742 | Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Plac |
| Q36475626 | Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib |
| Q46367849 | Combined glucosamine and chondroitin sulfate provides functional and structural benefit in the anterior cruciate ligament transection model. |
| Q87487744 | Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis |
| Q34517159 | Commonly Used Dietary Supplements on Coagulation Function during Surgery |
| Q36675924 | Comparative efficacy and safety study of two chondroitin sulfate preparations from different origin (avian and bovine) in symptomatic osteoarthritis of the knee |
| Q34188301 | Comparative therapeutic efficacy and safety of type-II collagen (UC-II), glucosamine and chondroitin in arthritic dogs: pain evaluation by ground force plate |
| Q37616246 | Comparing the effect of Glucosamine and Glucosamine With Alendronate in Symptomatic Relieve of Degenerative Knee Joint Disease: A Double- blind Randomized Clinical Trial Study |
| Q35642358 | Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis |
| Q21254655 | Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351] |
| Q87982631 | Comparison of the chondroprotective effect of a novel hydrogel compound and traditional hyaluronate on rat cartilage in a papain-induced osteoarthritis model |
| Q30363311 | Complementary therapies for cancer pain. |
| Q37772732 | Conservative treatment modalities and outcomes for osteoarthritis: the concomitant pyramid of treatment |
| Q35648416 | Constructing a self-care curriculum |
| Q90585111 | Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis |
| Q24630640 | Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties |
| Q37389534 | Current concepts in osteoarthritis |
| Q36059344 | Current evidence for osteoarthritis treatments |
| Q34027603 | Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. |
| Q38856377 | DRUG THERAPY IN KNEE OSTEOARTHROSIS. |
| Q34554878 | Daily oral consumption of hydrolyzed type 1 collagen is chondroprotective and anti-inflammatory in murine posttraumatic osteoarthritis. |
| Q36098910 | Del1 Knockout Mice Developed More Severe Osteoarthritis Associated with Increased Susceptibility of Chondrocytes to Apoptosis |
| Q41811588 | Design and Synthesis of Nanofibers of Self-assembled de novo Glycoconjugates towards Mucosal Lining Restoration and Anti-Inflammatory Drug Delivery |
| Q35656584 | Determination of glucosamine and its derivatives released from photocrosslinked gelatin hydrogels using HPLC. |
| Q36401915 | Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study |
| Q43076770 | Dietary glucosamine under question |
| Q36548695 | Dietary supplement adverse events: report of a one-year poison center surveillance project |
| Q33920880 | Dietary supplements as disease-modifying treatments in osteoarthritis: a critical appraisal |
| Q30235140 | Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment |
| Q38371965 | Discrepancies in composition and biological effects of different formulations of chondroitin sulfate. |
| Q36841160 | Does the evidence make a difference in consumer behavior? Sales of supplements before and after publication of negative research results |
| Q24197534 | Doxycycline for osteoarthritis of the knee or hip |
| Q37199641 | Drug insight: aggrecanases as therapeutic targets for osteoarthritis. |
| Q84448818 | Effect of 12 months treatment with chondroitin sulfate on cartilage volume in knee osteoarthritis patients: a randomized, double-blind, placebo-controlled pilot study using MRI |
| Q41636872 | Effect of Glucosamine Sulfate on Osteoarthritis in the Cruciate-Deficient Canine Model of Osteoarthritis |
| Q36230822 | Effect of a glucosamine-based combination supplement containing chondroitin sulfate and antioxidant micronutrients in subjects with symptomatic knee osteoarthritis: A pilot study |
| Q36156938 | Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients |
| Q34001775 | Effect of chondroitin sulphate in symptomatic knee osteoarthritis: a multicentre, randomised, double-blind, placebo-controlled study |
| Q89282120 | Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q50459670 | Effect of oral glucosamine on joint structure in individuals with chronic knee pain: a randomized, placebo-controlled clinical trial. |
| Q57343513 | Effect of stoichiometry and pH on the structure and properties of Chitosan/Chondroitin sulfate complexes |
| Q41530493 | Effect of strontium ranelate on pain behavior in an experimental model of osteoarthritis |
| Q35844016 | Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. |
| Q64137153 | Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials |
| Q93016657 | Effectiveness of Non-Animal Chondroitin Sulfate Supplementation in the Treatment of Moderate Knee Osteoarthritis in a Group of Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Pilot Study |
| Q37398414 | Effects of AIF on Knee Osteoarthritis Patients: Double-blind, Randomized Placebo-controlled Study |
| Q35147261 | Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids |
| Q43182266 | Effects of chondroitin sulfate and glucosamine in adult patients with Kaschin-Beck disease |
| Q37302467 | Effects of dietary supplementation with the solanaceae plant alkaloid anatabine on joint pain and stiffness: results from an internet-based survey study |
| Q36951422 | Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial |
| Q54493171 | Effects of glucosamine administration on patients with rheumatoid arthritis. |
| Q88528202 | Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis |
| Q24606203 | Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis |
| Q35732150 | Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint. |
| Q34345032 | Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials |
| Q36797781 | Efficacy and Safety of Zhuanggu Joint Capsules in Combination with Celecoxib in Knee Osteoarthritis: A Multi-center, Randomized, Double-blind, Double-dummy, and Parallel Controlled Trial |
| Q48085671 | Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study |
| Q28081360 | Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis |
| Q36517447 | Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study |
| Q38993297 | Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses |
| Q92416265 | Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials |
| Q37301182 | Efficacy of a natural mineral complex in North American adults with osteoarthritis of the knee: a randomized double-blind placebo-controlled study |
| Q33873723 | Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial. |
| Q24647966 | Eggshell membrane in the treatment of pain and stiffness from osteoarthritis of the knee: a randomized, multicenter, double-blind, placebo-controlled clinical study |
| Q24645101 | Eggshell membrane: a possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies |
| Q24647595 | Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system |
| Q37642204 | Evaluation of the effect of D-002, a mixture of beeswax alcohols, on osteoarthritis symptoms |
| Q38946274 | Evidence-Based Evaluation of Complementary Health Approaches for Pain Management in the United States. |
| Q36603277 | Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis |
| Q35630056 | Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta |
| Q33694487 | Extracellular matrix molecules: potential targets in pharmacotherapy. |
| Q36056916 | Focusing osteoarthritis management on modifiable risk factors and future therapeutic prospects |
| Q33874031 | Future directions for the management of pain in osteoarthritis |
| Q36173158 | Glucosamine Downregulates the IL-1β-Induced Expression of Proinflammatory Cytokine Genes in Human Synovial MH7A Cells by O-GlcNAc Modification-Dependent and -Independent Mechanisms |
| Q38362244 | Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants |
| Q40070187 | Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes. |
| Q34396147 | Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens |
| Q37354339 | Glucosamine and chondroitin for osteoarthritis |
| Q42330053 | Glucosamine and chondroitin for the treatment of osteoarthritis |
| Q34656760 | Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis |
| Q45916486 | Glucosamine and chondroitin sulfate in the management of osteoarthritis. Commentary. |
| Q41176136 | Glucosamine exposure reduces proteoglycan synthesis in primary human endothelial cells in vitro |
| Q21284705 | Glucosamine for osteoarthritis: biological effects, clinical efficacy, and safety on glucose metabolism |
| Q37069033 | Glucosamine hydrochloride for the treatment of osteoarthritis symptoms. |
| Q33368886 | Glucosamine increases hyaluronic acid production in human osteoarthritic synovium explants |
| Q38729322 | Glucosamine induces ER stress by disrupting lipid-linked oligosaccharide biosynthesis and N-linked protein glycosylation |
| Q22000860 | Glucosamine prevents in vitro collagen degradation in chondrocytes by inhibiting advanced lipoxidation reactions and protein oxidation |
| Q46434526 | Glucosamine sulfate might have no effect on pain or structural changes associated with osteoarthritis |
| Q45983328 | Glucosamine sulfate--environmental antibacterial activity. |
| Q34460174 | Glucosamine supplementation after anterior cruciate ligament reconstruction in athletes: a randomized placebo-controlled trial. |
| Q37960179 | Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations |
| Q24244026 | Glucosamine therapy for treating osteoarthritis |
| Q50057188 | Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort |
| Q107466751 | Glycosylation of SARS-CoV-2: structural and functional insights |
| Q39315179 | Guidelines for the use of nonsurgical interventions in osteoarthritis management |
| Q37454518 | Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions |
| Q34652562 | High-rosmarinic acid spearmint tea in the management of knee osteoarthritis symptoms |
| Q24633034 | How Much of CAM Is Based on Research Evidence? |
| Q57957379 | Human Articular Cartilage Proteoglycans Are Not Undersulfated in Osteoarthritis |
| Q34069452 | Immune modulation by chondroitin sulfate and its degraded disaccharide product in the development of an experimental model of multiple sclerosis |
| Q37310621 | Immunomodulatory and anti-inflammatory effects of chondroitin sulphate |
| Q44118071 | Importance of pharmaceutical composition and evidence from clinical trials and pharmacological studies in determining effectiveness of chondroitin sulphate and other glycosaminoglycans: a critique |
| Q37754703 | Inflammation and arthritis: perspectives of the glycobiologist |
| Q48232636 | Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines |
| Q24186414 | Intra-articular corticosteroid for knee osteoarthritis |
| Q43700545 | Intra-articular delivery of glucosamine for treatment of experimental osteoarthritis created by a medial meniscectomy in a rat model. |
| Q57389638 | Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial |
| Q44916982 | Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis? |
| Q21195259 | Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? |
| Q81382549 | Is treatment with chondroitin efficacious for osteoarthritis? |
| Q37773271 | Joint injury and osteoarthritis: soluble mediators in the course and treatment of cartilage pathology |
| Q24235493 | Joint lavage for osteoarthritis of the knee |
| Q57623647 | Knee effusion volume assessed by magnetic resonance imaging and progression of knee osteoarthritis: data from the Osteoarthritis Initiative |
| Q34624341 | Knee joint pain potentially due to bone alterations in a knee osteoarthritis patient |
| Q24200715 | Leeches (Hirudinea) for osteoarthritis |
| Q38669607 | Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study |
| Q39165523 | Liposomal formulation of chondroitin sulfate enhances its antioxidant and anti-inflammatory potential in L929 fibroblast cell line. |
| Q51392424 | Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. |
| Q84083786 | MR imaging of knee osteoarthritis and correlation of findings with reported patient pain |
| Q34459643 | Management of Osteoarthritis with Avocado/Soybean Unsaponifiables. |
| Q26773279 | Managing osteoarthritis |
| Q38258121 | Managing the pain of knee osteoarthritis |
| Q26767227 | Marine Origin Polysaccharides in Drug Delivery Systems |
| Q42326567 | Metabolomic analyses of blood plasma after oral administration of D-glucosamine hydrochloride to dogs |
| Q54199536 | Methodologic Questions Regarding Study of the Efficacy of Chondroitin Sulfate/Glucosamine Treatment of Knee Osteoarthritis: Comment on the Article by Roman-Blas et al. |
| Q58910693 | Micro- and Nano-Carrier Mediated Intra-Articular Drug Delivery Systems for the Treatment of Osteoarthritis |
| Q35523375 | Military-specific application of nutritional supplements: a brief overview. |
| Q37798321 | Modern Management of Mild-to-Moderate Joint Pain due to Osteoarthritis: A Holistic Approach |
| Q57445811 | Molecular pathogenesis and genetics of osteoarthritis: implications for personalized medicine |
| Q34896866 | Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow |
| Q48968123 | Multiple PRP injections are more effective than single injections and hyaluronic acid in knees with early osteoarthritis: a randomized, double-blind, placebo-controlled trial |
| Q34726514 | N-acylated glucosamines for bone and joint disorders: effects of N-butyryl glucosamine on ovariectomized rat bone |
| Q34978132 | New Frontiers for Cartilage Repair and Protection |
| Q37604878 | New methods to diagnose and treat cartilage degeneration. |
| Q38917888 | Non-operative management of osteoarthritis of the knee joint. |
| Q40504756 | Non-surgical treatment of osteoarthritis-related pain in the elderly |
| Q37417111 | Nonoperative treatment approach to knee osteoarthritis in the master athlete |
| Q28076979 | Nutraceutical Supplements in the Management and Prevention of Osteoarthritis |
| Q38047227 | Nutraceuticals in the management of osteoarthritis : a critical review |
| Q82671129 | Nutraceuticals: has there been any progress? |
| Q81241512 | Nutraceuticals: miracle or meme? |
| Q26860861 | Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis |
| Q35678507 | OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group |
| Q37324168 | Older adults' pain descriptions |
| Q47146827 | Opinion of the safety of glucosamine hydrochloride from Aspergillus niger as food ingredient |
| Q30537079 | Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis |
| Q58134533 | Oral Glucosamine Effect on Blood Glucose and Insulin Levels in Patients With Non-Diabetic Osteoarthritis: A Double-Blind, Placebo-Controlled Clinical Trial |
| Q39006999 | Oral glucosamine sulfate supplementation does not induce endoplasmic reticulum stress or activate the unfolded protein response in circulating leukocytes of human subjects. |
| Q24193560 | Oral or transdermal opioids for osteoarthritis of the knee or hip |
| Q24240601 | Oral or transdermal opioids for osteoarthritis of the knee or hip |
| Q30863651 | Osteoarthritis of the knee |
| Q35197619 | Osteoarthritis treatment using autologous conditioned serum after placebo. |
| Q41935934 | Osteoarthritis, a disease bridging development and regeneration |
| Q38739124 | Paracetamol and the placebo effect in osteoarthritis trials: a missing link? |
| Q35662150 | Patient satisfaction after total knee arthroplasty: an Asian perspective |
| Q36832428 | Patterns of arthritis medication use in a community sample |
| Q40190115 | Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). |
| Q37809746 | Pharmacologic therapy for osteoarthritis—the era of disease modification |
| Q44728458 | Pharmacological therapy of arthrosis |
| Q60959033 | Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline |
| Q33631650 | Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes |
| Q34112904 | Pharmacoproteomic study of three different chondroitin sulfate compounds on intracellular and extracellular human chondrocyte proteomes |
| Q33629459 | Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee |
| Q37261579 | Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer |
| Q37272696 | Physicians and nurses use and recommend dietary supplements: report of a survey |
| Q34636799 | Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities |
| Q34413209 | Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial. |
| Q56986258 | Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis |
| Q56988869 | Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions |
| Q37782597 | Polysaccharide-based materials for cartilage tissue engineering applications |
| Q37167150 | Potential effects of chondroitin sulfate on joint swelling: a GAIT report |
| Q93135737 | Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis |
| Q35039262 | Prescribing patterns of glucosamine in an older population: a national cohort study. |
| Q80395750 | Prescription of glucosamine for osteoarthritis: does it work and is it safe? |
| Q33845330 | Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study. |
| Q34157463 | Progress in complementary and alternative medicine research: Yale Research Symposium on Complementary and Integrative Medicine |
| Q38042037 | Quantifying clinically significant change: a brief review of methods and presentation of a hybrid approach |
| Q38959805 | Re: Eugene J. Kucharz, Volodymyr Kovalenko, Sándor Szántó, Olivier Bruyère, Cyrus Cooper & Jean-Yves Reginster (2016) A review of glucosamine for knee osteoarthritis: why patented crystalline glucosamine sulfate should be differentiated from other g |
| Q45778234 | Reversible binding and quantification of heparin and chondroitin sulfate in water using redox-stable biferrocenylene SAMs |
| Q38132674 | Rheumatologists' opinions towards complementary and alternative medicine: a systematic review |
| Q34570456 | Risk assessment for glucosamine and chondroitin sulfate |
| Q34423402 | Risk of bias and brand explain the observed inconsistency in trials on glucosamine for symptomatic relief of osteoarthritis: a meta-analysis of placebo-controlled trials. |
| Q34264613 | Role of glucosamine in the treatment for osteoarthritis |
| Q24240483 | S-Adenosylmethionine for osteoarthritis of the knee or hip |
| Q46175901 | Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial |
| Q38541866 | Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend? |
| Q37393275 | Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial |
| Q64245298 | Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis |
| Q47151673 | Scientific Opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13(5) of Regulation (EC) No 1924/2006 |
| Q47147618 | Scientific Opinion on the substantiation of a health claim related to glucosamine hydrochloride and reduced rate of cartilage degeneration and reduced risk of development of osteoarthritis pursuant to Article 14 of Regulation (EC) No 1924/2006 |
| Q42135777 | Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties |
| Q33275599 | Selection of reliable reference genes for qPCR studies on chondroprotective action |
| Q36654870 | Serum Metabolite Profiles Are Altered by Erlotinib Treatment and the Integrin α1-Null Genotype but Not by Post-Traumatic Osteoarthritis |
| Q36471998 | Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials |
| Q89736179 | Small Leucine-Rich Proteoglycans in Skin Wound Healing |
| Q33546740 | Sodium pentosan polysulfate resulted in cartilage improvement in knee osteoarthritis--an open clinical trial |
| Q89165226 | Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review |
| Q26768544 | Surface Proteoglycans as Mediators in Bacterial Pathogens Infections |
| Q36225456 | Symptom assessment in knee osteoarthritis needs to account for physical activity level. |
| Q33851507 | Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine |
| Q46259879 | Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee |
| Q36633149 | Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. |
| Q52652154 | The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells. |
| Q64258807 | The Effects of Glucosamine and Chondroitin Sulfate on Gut Microbial Composition: A Systematic Review of Evidence from Animal and Human Studies |
| Q42728527 | The Effects of Morus alba and Acacia catechu on Quality of Life and Overall Function in Adults with Osteoarthritis of the Knee |
| Q41966032 | The Fate of Oral Glucosamine Traced by (13)C Labeling in the Dog. |
| Q36042425 | The PLE(2)NO self-management and exercise program for knee osteoarthritis: Study Protocol for a Randomized Controlled Trial |
| Q34318992 | The Pathophysiology and Progression of Hip Osteoarthritis Accompanied with Joint Pain are Potentially Due to Bone Alterations - Follow-up Study of Hip OA Patients |
| Q36919005 | The association of proximal femoral shape and incident radiographic hip OA in elderly women |
| Q90454112 | The bulge sign - a simple physical examination for identifying progressive knee osteoarthritis: data from the Osteoarthritis Initiative |
| Q33239303 | The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta |
| Q52859304 | The comparison of the effects of a novel hydrogel compound and traditional hyaluronate following micro-fracture procedure in a rat full-thickness chondral defect model. |
| Q24630475 | The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial |
| Q37222989 | The effect of pain question phrasing on older adult pain information |
| Q55433093 | The effect of whole-body vibration training on the lower extremity muscles' electromyographic activities in patients with knee osteoarthritis. |
| Q33317819 | The effectiveness of pulsed electrical stimulation (E-PES) in the management of osteoarthritis of the knee: a protocol for a randomised controlled trial. |
| Q37667284 | The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial |
| Q33556721 | The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis |
| Q45969369 | The glucosamine debate: is it better than placebo? |
| Q33679221 | The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination |
| Q37049693 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37154872 | The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritis |
| Q37228620 | The potential of chondroitin sulfate as a therapeutic agent |
| Q36298442 | The repair of full-thickness articular cartilage defect using intra-articular administration of N-acetyl-D-glucosamine in the rabbit knee: randomized controlled trial |
| Q36719696 | The reverse glucosamine sulfate pathway: application in knee osteoarthritis |
| Q37825835 | The role of ADAMTSs in arthritis |
| Q36503913 | The role of sleep problems in central pain processing in rheumatoid arthritis |
| Q37523942 | The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making. |
| Q30540752 | The use of glucosamine for chronic low back pain: a systematic review of randomised control trials |
| Q33854784 | The use of pure and impure placebo interventions in primary care - a qualitative approach |
| Q36793235 | The utility of nutraceuticals in the treatment of osteoarthritis |
| Q34088913 | Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs |
| Q24240366 | Therapeutic ultrasound for osteoarthritis of the knee or hip |
| Q24240643 | Transcutaneous electrostimulation for osteoarthritis of the knee |
| Q46244375 | Treatment of osteoarthritis with drugs and other modalities |
| Q37858371 | Treatment options for osteoarthritis: considerations for older adults |
| Q57211788 | Treatment patterns of knee osteoarthritis patients in Korea |
| Q38405295 | Trends in Dietary Supplement Use Among US Adults From 1999-2012. |
| Q63352658 | Type 2 diabetes mellitus and osteoarthritis |
| Q43201198 | Unusual case of drug-induced cholestasis due to glucosamine and chondroitin sulfate |
| Q36891196 | Use of autologous conditioned serum (Orthokine) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literature |
| Q37418396 | Use of complementary and alternative therapies by overweight and obese adults |
| Q34668295 | Use of dietary supplements by cardiologists, dermatologists and orthopedists: report of a survey |
| Q35220305 | Use of glucosamine and chondroitin and lung cancer risk in the VITamins And Lifestyle (VITAL) cohort |
| Q36570336 | Use of glucosamine and chondroitin in relation to mortality |
| Q36900371 | Use of glucosamine and chondroitin supplements and risk of colorectal cancer. |
| Q39644887 | Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals follow-up study |
| Q91867823 | Use of glucosamine and chondroitin to treat osteoarthritis: a review of the literature |
| Q37131021 | Use of recommended osteoarthritis pain treatment by older adults |
| Q39124560 | Using glucosamine to improve the properties of photocrosslinked gelatin scaffolds |
| Q64933398 | Variability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. |
| Q47650325 | West meets east--observations on integrative medicine in rheumatology from the USA. |
| Q37868775 | What about supplements for osteoarthritis? A critical and evidenced-based review |
| Q44039826 | What is a food and what is a medicinal product in the European Union? Use of the benchmark dose (BMD) methodology to define a threshold for "pharmacological action". |
| Q33527138 | What rheumatologists in the United States think of complementary and alternative medicine: results of a national survey |
| Q93746929 | What's new in the other general journals |
| Q84949150 | [Conservative treatment of arthrosis between evidence, consensus and nonsense] |
| Q84600460 | [Do disease modifying drugs exist for osteoarthritis] |
| Q87168539 | [Osteoarthritis: what internists should know] |
| Q88336488 | [Pharmacological treatment of osteoarthritis-related pain] |
Search more.